Adaptive Biotechnologies Corp

ADPTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$277.0M

▲ 54.8% YoY

Net Income

-$59.5M

▲ 62.7% YoY

EPS

$-0.39

▲ 63.9% YoY

Cash

$70.5M

▲ 47.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.